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Consequences of the AF-2 Incident in
Japan
by Y. Tazima*
The discovery ofthe potent mutagenicity ofAF-2, which wasonce used in Japan as a food preservative,
has exerted a great influence not only on screening procedures for carcinogenic compounds but also on
legislative approaches to mutagenic substances. It promoted the synthesis of exceedingly sensitive and
reliable tester strains in Salmonella and supported the hypothesis of a common mechanism between
mutagenicity and carcinogenicity. Thus preliminary screening for carcinogenic substances has become
feasible using mutagenicity as an index. It also contributed greatly to the formulation of legislative
measures for chemical substances which for the first time gave due attention to mutagenicity. Fur-
thermore, the exposure ofa large population to such a potent mutagen raised a question as to what extent
the genetic constitution ofthe Japanese population might have been damaged. This suggested the urgent
need for a system to monitor the total genetic damage to a human genome.
AF-2 was used as a food preservative in Japan
during the years 1965-1974. It was widely used in
foods like soybean curd (t6fu), ham, sausage; fish
ham, fish sausage, and fish paste (kamaboko) to
prevent contamination by microorganisms. Its
chemical structure is 2-(2-furyl)-3-(5-nitro-2-furyl)
acrylamide, abbreviated furylfuramide.
The discovery of the potent mutagenicity of this
compound initially produced extraordinarily heated
discussion in Japan. It is not pleasant for me to
recollect those days, but the discovery brought
about several far-reaching effects not only upon
legislative approaches to mutagenic substances but
also upon scientific development in relevant fields.
Just before the establishment of the Environ-
mental Mutagen Society ofJapan a research group
was organized for the promotion of studies on en-
vironmental mutagens. Each member, using his
most familiar test system, focused on the develop-
ment of sensitive test systems for weak mutagens
and chose a few nitrofuran derivatives, including
AF-2, as standard test chemicals for comparing
different test systems. AF-2 was included because it
was widely used in Japan at that time and because
mutagenicity and carcinogenicity had already been
demonstrated for several other nitrofuran com-
pounds. However, we did not know that a producer
of AF-2 had instituted legal proceedings against an
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author of a book claiming damages caused by the
latter's severe criticism of this compound. This
added to the complexity of our dispute when we
discovered and reported the potent mutagenicity of
AF-2.
In what follows I shall describe some conse-
quences ofthe discovery ofthe potent mutagenicity
of AF-2.
Scientific Contributions
Promotion of the Improvement of the
Salmonella Test System
At the first joint meeting of the US-Japan
Mutagenesis and Carcinogenesis Panel held in
Tokyo in August of 1972, Ames (I) talked about the
usefulness of the Salmonella test strains TA1535,
TA1536, TA1537, and TA1538, which were capable
of detecting the mutagenicity of a wide range of
chemicals. In the meantime our research group dis-
covered the strong mutagenicity of AF-2 with sev-
eral test systems: colon bacteria (2, 3), yeast (4),
silkworm (5), and human cells in culture (6). Soon
afterwards Sugimura et al. (7) noticed that the
available Salmonella TA systems were unable to
detect the mutagenicity of AF-2 as well as other
nitrofuran compounds. This finding was communi-
cated by Sugimura at the secondjoint meetingofthe
US-Japan Panel on Mutagenesis and Car-
cinogenesis held at Charleston in 1973. Since then,
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monella system was energetically pushed by Ames'
group. At the Honolulu Workshop held in De-
cember of 1974, McCann (8) reported success in the
synthesis of strains TA98 and TAIOO, which do re-
spond to AF-2, to other nitrofurans, and to other
compounds which had previously given a negative
response, such as benzyl chloride, benzo(a)pyrene,
7,12-dimethylbenzanthracene, and acetoxysafrol. It
may be too much to say that this improvement of
the Salmonella strains was due to the AF-2 incident
alone, but it appears certain that the compound
promoted the synthesis of these strains.
Utility of Mutagenicity as an Index for
Screening Carcinogenicity
Extensive research was carried out by Miyaji (9,
10) at Osaka University to test the toxicity and car-
cinogenicity of AF-2 on rats; but the results were
reported to be negative. On the basis of these and
some other results, the Food Sanitary Council per-
mitted the use ofAF-2 as afood preservative. How-
ever, since strong mutagenicity was revealed with
this compound, later careful examinations were
conducted by many investigators to test for car-
cinogenicity. Several positive results were ob-
tained, and nowadays there is no room for doubt
that the compound is carcinogenic. The differences
in experimental conditions between studies carried
out at early and late stages were in dose and use of
sensitive conditions.
Dose. In Miyaji's experiments, doses were rel-
atively low, less than half of the later experi-
menter's, because Miyaji thought highly of doses
administered at food-additive concentrations. The
higher doses used in later experiments enabled the
demonstration of the carcinogenicity of AF-2
(11-14).
Highly Sensitive Conditions. In later experi-
ments testing was performed under highly sensitive
conditions, i.e., using young animals (15, 16), under
elevated enzyme activity induced by phenobarbital,
PCB (8, 17, 18), or transplacental administration of
test compounds to fetuses in utero (19). The results
clearly indicated that mutagenicity could be used as
an appropriate index for the screening of car-
cinogenicity. This view was completely supported
by testing the mutagenicity of several carcinogens
with Salmonella.
Using improved Salmonella strains, in combina-
tion with S9 when necessary, Ames etal. (20)tested
the mutagenicity of many compounds whose car-
cinogenicity was already known. The results were
positive for the majority of compounds tested.
This led Ames to conclude that carcinogens are
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mutagens. For the purpose of screening for car-
cinogenicity, experimentation on a large scale is re-
quired consuming large amounts of money, man-
power and time. The exploitation of the improved
Salmonella system made it feasible to preselect
suspicious substances for carcinogenicity testing by
prior mutagenicity testing.
Impact on Legislative
Requirements
For safety testing offood additives, the following
had already been legislated as essential: acute tox-
icity, chronic toxicity, teratogenicity, and car-
cinogenicity. In addition, it has often been pointed
out that mutagenicity should also be taken into con-
sideration. No country has as yet designated
mutagenicity tests as compulsory. In Japan, how-
ever, mutagenicity is now regarded as a quasi-
compulsory item for safety evaluation offood addi-
tives.
As mentioned before, soon after the start of our
research group in 1972, Tonomura and Sasaki (6)
observed the strong chromosome breaking capacity
ofAF-2 using a cytogenetic test system with human
lymphocytes. Furamizole, Nitrofurylacrylamide
(Z-furan), Furypyrinole, and Furylfuramide (AF-2)
were active in decreasing order. The most as-
tonishing finding was that AF-2 was included in the
active group. Tonomura immediately informed the
group members of these findings. Thereafter, the
mutagenicity of this compound was demonstrated
by other members of the group with various test
systems: E. coli (2, 3), B. subtilis (3), yeast (4), and
the silkworm (5). Independently of this group,
Sugimura and his collaborators (7) confirmed the
strong mutagenicity of AF-2 in bacteria using both
the Salmonella repair test and the E. coli WP-2 test.
Although mutagenic activity had not yet been de-
tected by in vivo experiments with mammals, it was
conjectured that the compound might also be
mutagenic to man since mutagenicity had been ob-
served in such a wide range of test systems.
We therefore warned our government ofthe pos-
sible genetic danger of this compound and re-
quested them to perform careful safety tests on
mammals. The authorities, however, did not listen
to our caution. Half a year later, we released our
results to the press on the occasion of the annual
meeting of the Environmental Mutagen Society of
Japan held in September of 1973. Thereafter, long
and disagreeable disputes arose between govern-
ment authorities and ourselves (21, 22). As a rep-
resentative of the Society, I was threatened by a
company that produces AF-2, saying that they
would take legal action for damages. We were even
Environmental Health Perspectivescriticized by some scientists for causing a sensation.
In vivo mutagenicity data on mammals were keenly
sought.
Nakagawa, working under Miyaji, reported
negative results from his in viv'o cytogenetic study
on mice following orally administered AF-2 (23).
Similar tests carried out on mice by Yosida, head of
the Cytogenetics Department of our Institute, was
also yielding negative results. However, the pre-
dicted positive results were obtained by Sugiyama
et al. (15). By administering AF-2 intraperitoneally
and/or orally to young rats ofthe Long-Evans strain
he clearly demonstrated that AF-2 breaks bone
marrow chromosomes in viv'o, and he even
suggested that it might well be carcinogenic.
Sugiyama's success was completely due to the use
of young animal. Their results were soon confirmed
by my colleague Yosida (16). Thus our belief that
AF-2 is harmful to human beings was reinforced.
In the meantime, Japanese governmental au-
thorities became aware of developing attitudes in
western countries where genetic safety was taken
into consideration in the safety examination offood
additives. They reorganized the Food Sanitary
Council, an advisory organ to the Minister ofHealth
and Welfare, and set up a committee for the evalua-
tion of genetic safety (July 1974). The committee,
after formulating principles and standard test sys-
tems for the evaluation ofgenetic safety, evaluated
the mutagenicity of AF-2 with the data thus far ob-
tained.
The compound was negative in the dominant le-
thal test in mice. These tests were carried out in
three laboratories: the National Institute of
Hygienic Sciences, Tokyo (24); the National Insti-
tute of Genetics, Mishima (25); and, in the United
States, the National Institute of Environmental
Health Sciences, Research Triangle Park, North
Carolina (26). Midway data collected at that time
from these institutes were all negative. The final
NIEHS report is now available. In their experiment
five groups were run, each comprising more than
500 fertile matings and collecting data for six con-
secutive weeks. AF-2 doses were 0, 300, 350, 400,
and 450 mg/kg. Again there was no indication of
AF-2-induced dominant lethality.
The host-mediated assay, carried out by
Tutikawa and Kada (25) by injecting B. slbtilis into
the peritoneum of mice, gave clearly positive re-
sults, indicating that the genetic toxicity of AF-2
was maintained for at least a few hours after oral
administration.
Taking this evidence together with the aforemen-
tioned in vivo cytogenetic data, the committee con-
cluded that AF-2 was very likely to be mutagenic to
man. The committee submitted their report to the
Minister, recommending that the use of AF-2 as a
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food preservative should be prohibited (September,
1974). By this time preliminary data demonstrating
the carcinogenicity ofAF-2 had been obtained by a
research team headed by Ikeda (11) at the National
Institute of Hygienic Sciences. The Government
immediately took action to ban the use ofthis com-
pound. In the work by Ikeda et al., diets containing
AF-2 were given continuously to ddY/SLC mice.
Squamous cell carcinoma was induced in the
forestomach within a year.
Since then, positive results have been obtained
by many workers in both mutagenicity and car-
cinogenicity tests.
Nomura (1975) (27) reported that three sub-
cutaneous injections of AF-2 (50 ,g/g body weight)
into pregnant mice resulted in lung adenoma in
17.1% of their offspring. This was significantly
higher than the 2.7% observed in the control group.
Takayama and Kuwabara (13) observed the induc-
tion of mammary tumors in Wister rats by feeding
AF-2. Sano et al. (12) reported the production of
squamous cell carcinomas in golden hamster cheek
pouches by feeding a diet containing 0.25% AF-2.
They also reported the induction of similar car-
cinomas in the forestomachs ofmice. Yokoro et al.
(14) were able to produce squamous cell carcinomas
in the forestomachs of mice by feeding. Inui et al.
(/9) reported the neoplastic transformation of em-
bryonic hamster cells after transplacental adminis-
tration of AF-2 in the pregnant mother. Aoki et al.
(28) reported hepatic changes in the teleost Oryzias
latipes when they were raised for 2-3 months in
water containing 2-5 jig/ml AF-2.
Regarding the mutagenicity of AF-2, further
positive results were obtained by many inves-
tigators: in Neutrospora c rassa by Ong et al. (29), in
Saccharomyces cerei'isiae by Shahin et al. (30), in
human diploid cells by Kuroda (31), in Chinese
hamster cells by Wild (32) and by Ban et al. (33), in
mouse lymphoma cells by Nakamura et al. (18), and
in the mouse micronucleus test by Goodman et al.
(34).
These results justified the decision of the Food
Sanitary Council. It must be noted, however, that
their reason for banning AF-2 was not due to
mutagenicity, but to carcinogenicity. On the other
hand, if mutagenicity had not been detected, this
compound would have continued in use.
It is strongly urged that mutagenicity should be
regarded as one of the compulsory items for safety
evaluation of chemicals.
Suggestion for Future Research
The discovery ofthe potent mutagenicity ofAF-2
raised the question of the extent to which the ge-
netic makeup ofthe Japanese population might have
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have been exposed to such mutagens, namely
AF-2 for 9 years (1965-1974) and Z-furan (nitro-
furylacrylamide), a more potent mutagen than the
former, for 11 years (1954-1965). Although daily
intakes of these mutagens were very small, the ac-
cumulated dose was thought to reach appreciable
levels.
The magnitude of this exposure can be roughly
estimated as follows in terms ofthe radiation equiv-
alent chemical. The annual production of AF-2, al-
though not made public, is guessed to be about 3.5
tons in 1973. The biological activity of AF-2 is
known to decline in foodstuffs while they are on the
shelf in the market. The average decay factor is
assumed to 0.95 per total foodstuffs frQm produc-
tion to ingestion (2). The substantially active
amount is, therefore, calculated to be 3.5 ton x (I -
0.95) = 175 kg/year. The mutagenic activity ofAF-2
in reproductive cells of mammals has not been de-
termined yet. Hence, data obtained in the silkworm
will be used instead (35). In this insect the muta-
tion rate was obtained by oocytes by injecting the
chemical into the body cavities of female pupa.
RECs obtained in the silkworm are 20 to 70 rem for
an administered dose I ,mg per insect, the average
body weight of which is I g. Hence 40 rem will be
taken as a representative value.
A dose of 1,4g/g for the silkworm is assumed to
correspond to 50 mg/50 kg for the average Japanese.
Therefore, 1 mg of AF-2 can be equated to 0.8 rem
exposure to y-rays per average person. We also as-
sume that the mutagenic efficiency of AF-2 in man
is 100 to 1000 times lower than in the silkworm,
taking several factors into consideration: injection
vs. ingestion, difference in time during which the
chemical remains active in the body, differential
sensitivity of germ cells, etc. In the silkworm AF-2
was injected into the body cavity and it, if not de-
composed, remained in the pupal body until
emergence ofthe moth. The mutation assay system
used for the silkworm experiment was a specific loci
method in which wild type oocytes were treated.
The system is very sensitive and gives mutation fre-
quencies at least 10 times higher than the sper-
matogenic cell system in the same insect.
With these assumptions, the average exposure
equivalent per Japanese is calculated as follows: 0.8
rem x 175 kg/mg x (10-2_10-3)/108 = 14.0-1.4
mrem/year. This is not large, and the genetic effects
ofsuch a small dose ofexposure to AF-2 may not be
detectable in practice. One may notice, however,
the vagueness in assuming a conversion factor from
the silkworm to man. Based on their data on the
mouse sarcoma assay system, Nakamura et al. (18)
calculated RECs of AF-2 to be 40 mrem per person
per year, taking into due consideration the propor-
tion of ingested AF-2 incorporated into gonads.
Still, several ambiguous factors were involved.
Since an AF-2-induced mutation rate is not avail-
able even in the mouse, there is an urgent need for
work to estimate the genetic risk to man. In this
connection, de Serres (36) stressed the urgency of
exploiting a system to monitor the total genetic
damage inflicted upon the human genome.
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